Dr. Jennifer L. Graham, MD Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 123 Andover Rd, Westbrook, ME 04092 Phone: 207-761-2200 Fax: 207-761-2108 |
Kasey May Moss, D.O. Psychiatry & Neurology - Child & Adolescent Psychiatry Medicare: Medicare Enrolled Practice Location: 123 Andover Rd, Westbrook, ME 04092 Phone: 207-761-2200 Fax: 207-761-2108 |
Dr. Sara Powers, M.D. Psychiatry & Neurology - Psychiatry Medicare: Medicare Enrolled Practice Location: 123 Andover Rd, Westbrook, ME 04092 Phone: 207-761-2200 |
Dr. Hannah Burley, MD Psychiatry & Neurology - Psychiatry Medicare: Medicare Enrolled Practice Location: 123 Andover Rd, Westbrook, ME 04092 Phone: 207-761-2200 |
Kathryn Anne Yung, MD Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 40 Park Rd, Westbrook, ME 04092 Phone: 207-857-8282 Fax: 207-857-8009 |
Dr. Daniel A Holliday, DO Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 123 Andover Rd, Westbrook, ME 04092 Phone: 207-761-2200 Fax: 207-761-2202 |
Daria M Hanson, MD Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 123 Andover Rd, Westbrook, ME 04092 Phone: 207-761-2200 Fax: 207-842-7773 |
News Archive
Age may cause identical cancer cells with the same mutations to behave differently. In animal and laboratory models of melanoma cells, age was a primary factor in treatment response.
Level IV Trauma Center Accreditation status has been granted to an additional hospital in Pennsylvania for the period from November 1, 2014 through October 31, 2015.
A collaborative research effort by Australian and US scientists has led to the discovery of a promising new approach to treating some of the worst types of leukaemia, including an aggressive leukaemia that mostly affects babies.
Patients with obstructive sleep apnea (OSA) who also suffer from depression often find that continued use of continuous positive airway pressure (CPAP) relieves them of symptoms of depression, according to a study published in the October 15 issue of the Journal of Clinical Sleep Medicine (JCSM).
Aeterna Zentaris Inc. today presented posters on encouraging preclinical results for AEZS-129 and AEZS-132, two novel orally active compounds with anti-tumor effects.
› Verified 9 days ago